News

News Filters

NHIF: Supporting home infusion

The National Home Infusion Foundation (NHIF) invests in and performs research as well as recognizes and supports outstanding home infusion professionals and their work.
SITE: nhia
Last week concluded the 2024 National Home Infusion Association Annual Conference (NHIA 2024), which brings together more than 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits.
SITE: nhia
The National Home Infusion Association has announced the finalists for its 2024 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
SITE: nhia
CMS released its annual monitoring report[link] on the Medicare Part B Home Infusion Therapy (HIT) Services benefit showing that both provider participation and beneficiary utilization have declined over the past year.
SITE: nhia
The National Home Infusion Association (NHIA) and Managed Health Care Associates, Inc. (MHA) are pleased to announce the addition of MHA to NHIA’s Future of Infusion Advisory Council (FIAC).
SITE: nhia
The National Home Infusion Association (NHIA) is proud to announce that Jeannie Counce, NHIA’s long-time Editor in Chief of INFUSION magazine is the recipient of the 2024 Gene Graves Lifetime Achievement Award.
SITE: nhia
The National Home Infusion Association (NHIA) has developed recommendations for commercial, Medicaid, and Medicare Advantage payors to improve patient outcomes and experience, reduce administrative burden, and improve timely access to home infusion services.

FDA Issues Guidance for Decentralized Clinical Trials

NHIA applauds the guidance issued by FDA to allow for decentralized clinical trials, including in patients’ homes. NHIA believes that allowing decentralized clinical trials will improve the representation in trials. According to the FDA guidance, “remote clinical trial visits and clinical trial-related activities are important strategies to make trials more convenient and more accessible” and “sponsors should strive for diversity and inclusiveness in trial populations.”

Read More »

NHIA 2023 Draws Record Attendance, Focuses on Future of Health Care and Health Equity

Last week concluded the 2023 National Home Infusion Association (NHIA) Annual Conference, which brings together nearly 1,500 home and alternate site infusion professionals for four days of networking, education, and expo. This year’s event saw significant growth in attendance over prior years and the expo featured more than 125 companies displaying the latest products and services supporting the industry.

Read More »

NHIA 2023 Tuesday – Health Equity in Home Infusion

Eliminating the inequities in how people access and receive health care can go a long way toward improving health care delivery, outcomes, and population health, according to Christina Ritchey from Optum Infusion Pharmacy. Equity in health care means the state in which everyone has a fair and just opportunity to attain their highest level of health.

Read More »

NHIA 2023 Monday, March 27 Recap

Attendees gathered for a morning coffee break after an engaging breakfast symposium from IgNS on PANS/PANDAS in Children. The beautiful backdrop overlooking the Potomac played host to some excellent conversations among professionals as everyone fueled up for a jam-packed day of education.

Read More »

NHIA 2023 Session Highlight: Navigating Post-Pandemic Stress for You and Your Team

As we enter the third year since the global pandemic and a return to “normal,” you might expect that trauma and anxiety related to the crisis would be waning. In fact, the opposite is true, according to Alissa Putman, PhD with Johns Hopkins Community Physicians. In 2022, 65% of psychologists reported an increase in symptom severity, including stress, anxiety, and depression. All of which can affect health care’s most precious resource: its workers.

Read More »

NHIA 2023 Sunday, March 26 Recap

With record attendance and beautiful spring weather in D.C., we had a full first day of action at NHIA 2023, starting off early with our three preconference seminars: Executive, Sterile Compounding and Revenue Cycle, covering valuable information for professionals in a variety of roles.

Read More »

NHIF Announces Finalists for 2023 Outstanding Abstract Achievement Award

The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2023. The authors of the following 6 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.

Read More »

NHIA Announces 2023-2024 Board of Directors

The National Home Infusion Association (NHIA) is proud to announce its 2023-2024 Board of Directors. Beginning this term, the association expanded to 15 the number of board seats on its governing body to provide a broader diversification of infusion provider organizations. Board members serve 3-year terms as representatives for their NHIA member organization.

Read More »

Impact of Pandemic-Related Drug and Supply Shortages on the Home and Alternate Site Infusion Industry

The National Home Infusion Association (NHIA) has prepared a white paper summarizing the impact of cost increases incurred by infusion providers due to pandemic-related supply shortages with a particular focus on parenteral nutrition (PN) components and disposable supplies. NHIA found that prices for PN components and disposable items rose dramatically during the pandemic due to supply chain challenges and shortages.

Read More »

Cost Savings: Home Versus Inpatient Infusion Therapy, A Review of the Literature

Home infusion is a site of care (SOC) option for patients requiring intravenous (IV) or subcutaneous (SC) medications for treatment of acute and chronic medical conditions. Patients and payors have become aware of the sizeable cost savings associated with home infusion when compared to other SOC. There is a need to gain an understanding of the amount of savings associated with home infusion when compared to other SOCs such as the hospital. The literature review objective is to provide a critical evaluation of the current evidence of the cost savings associated with home and outpatient infusion therapy when compared to inpatient therapy.

Read More »

CMS Releases Home Health Proposed Rule for CY 2024

On Friday June 30, 2023, CMS released proposed updates to the Medicare Home Health Prospective Payment System for CY 2024. The proposed home health rule does not address home infusion therapy (HIT) services other than to describe the potential interaction with the new Home IVIG Items and Service benefit, which replaces the IVIG demonstration starting on January 1, 2024. 

Read More »

FDA Issues Guidance for Decentralized Clinical Trials

NHIA applauds the guidance issued by FDA to allow for decentralized clinical trials, including in patients’ homes. NHIA believes that allowing decentralized clinical trials will improve the representation in trials. According to the FDA guidance, “remote clinical trial visits and clinical trial-related activities are important strategies to make trials more convenient and more accessible” and “sponsors should strive for diversity and inclusiveness in trial populations.”

Read More »

NHIA 2023 Draws Record Attendance, Focuses on Future of Health Care and Health Equity

Last week concluded the 2023 National Home Infusion Association (NHIA) Annual Conference, which brings together nearly 1,500 home and alternate site infusion professionals for four days of networking, education, and expo. This year’s event saw significant growth in attendance over prior years and the expo featured more than 125 companies displaying the latest products and services supporting the industry.

Read More »

NHIA 2023 Tuesday – Health Equity in Home Infusion

Eliminating the inequities in how people access and receive health care can go a long way toward improving health care delivery, outcomes, and population health, according to Christina Ritchey from Optum Infusion Pharmacy. Equity in health care means the state in which everyone has a fair and just opportunity to attain their highest level of health.

Read More »

NHIA 2023 Monday, March 27 Recap

Attendees gathered for a morning coffee break after an engaging breakfast symposium from IgNS on PANS/PANDAS in Children. The beautiful backdrop overlooking the Potomac played host to some excellent conversations among professionals as everyone fueled up for a jam-packed day of education.

Read More »

NHIA 2023 Session Highlight: Navigating Post-Pandemic Stress for You and Your Team

As we enter the third year since the global pandemic and a return to “normal,” you might expect that trauma and anxiety related to the crisis would be waning. In fact, the opposite is true, according to Alissa Putman, PhD with Johns Hopkins Community Physicians. In 2022, 65% of psychologists reported an increase in symptom severity, including stress, anxiety, and depression. All of which can affect health care’s most precious resource: its workers.

Read More »

NHIA 2023 Sunday, March 26 Recap

With record attendance and beautiful spring weather in D.C., we had a full first day of action at NHIA 2023, starting off early with our three preconference seminars: Executive, Sterile Compounding and Revenue Cycle, covering valuable information for professionals in a variety of roles.

Read More »

NHIF Announces Finalists for 2023 Outstanding Abstract Achievement Award

The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2023. The authors of the following 6 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.

Read More »

NHIA Announces 2023-2024 Board of Directors

The National Home Infusion Association (NHIA) is proud to announce its 2023-2024 Board of Directors. Beginning this term, the association expanded to 15 the number of board seats on its governing body to provide a broader diversification of infusion provider organizations. Board members serve 3-year terms as representatives for their NHIA member organization.

Read More »